Skip to main content
Premium Trial:

Request an Annual Quote

Ruedi Aebersold to Go from ISB to ETH; Collaboration Between Institutes Planned

NEW YORK, Sept. 18 (GenomeWeb News) - Ruedi Aebersold, co-founder of the Institute for Systems Biology in Seattle, will move back to Switzerland within the next 18 months to be Professor of Systems Biology at ETH, the Swiss Swiss Federal Institute of Technology in Zurich, the ISB said today.

 

Aebersold, a Swiss national who has led ISB's proteomics program since the institute's launch in 2000, will continue to spend nearly a quarter of his time at ISB after he moves to his new post in Switzerland, according to the ISB.  Nevertheless, ISB said it is looking for new faculty in order to augment its proteomics program.

 

"Earlier this year, ETH leadership extended to Ruedi an extraordinary offer in the context of an interdisciplinary 'faculty cluster' focused on systems biology at ETH Zurich," Leroy Hood, president of the ISB, said in a statement. "The position confers great prestige in Ruedi's homeland and truly represents a once in a lifetime opportunity. In addition, it provides an exciting new opportunity for the Institute to partner with a world class institution -- and one that is recognizing the important role that systems biology will play in transforming biology and medicine in the 21st century."

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.